Home > Boards > US OTC > Basic Materials > Bioxytran Inc. (BIXT)

$BIXT The device measures 4 parameters and

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mtrendspotter Member Profile
 
Followed By 9
Posts 1,113
Boards Moderated 0
Alias Born 08/06/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2020 2:35:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2020 4:01:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 2:40:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/6/2020 4:27:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2019 7:53:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2019 5:09:27 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 1:20:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 3:09:24 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 11/5/2019 3:36:26 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/5/2019 1:51:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2019 9:14:38 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 2:57:37 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 3:55:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 3:33:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 9:03:15 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/30/2019 9:51:25 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/30/2019 9:49:39 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/30/2019 9:47:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2019 1:30:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 2:47:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 9:40:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/26/2019 5:23:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2019 4:26:45 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/13/2019 6:25:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2019 10:09:20 AM
mtrendspotter   Friday, 05/24/19 09:30:45 AM
Re: None
Post # of 505 
$BIXT The device measures 4 parameters and uses an algorithm to calculate the Tissue Metabolic Score. The primary concept that underpins the technology is Oxygen Balance Homeostasis that dates back to 1914. The principal of Oxygen Balance Homeostasis is that organs are unable to increase their activity without a corresponding increase in oxygen consumption delivered by increased blood flow. Monitoring the TMS in certain less vital organs serves a proxy of tissue health in the most vital organs. The MDX viewer uses a minimally invasive multiparametric monitoring device connected to the patient’s urethral wall via a 3-way Foley catheter to measure TMS. When vital organs in the body are stressed, blood flow is diverted from less vital organs to the most vital organs and the TMS will fall. These changes can be measured with the MDX viewer to track tissue oxygenation levels in vital organs. A key case study done in cardiovascular operated patients underwent bypass of the coronary arteries procedure. During this type of operation, the TMS of the Urethral wall decreased significantly and then recovered toward the end of the operation as expected.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist